• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用天然微小RNA前体构建靶向肝癌的人工微小RNA

Construction of HCC-targeting artificial miRNAs using natural miRNA precursors.

作者信息

Huang Xiaoming, Jia Zhenyu

机构信息

Institute of Hygiene, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang 310013, P.R. China.

出版信息

Exp Ther Med. 2013 Jul;6(1):209-215. doi: 10.3892/etm.2013.1111. Epub 2013 May 14.

DOI:10.3892/etm.2013.1111
PMID:23935748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3735510/
Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, particularly in developing countries. Despite the achievements in clinical therapeutics, the HCC mortality rate remains high. A number of artificial microRNA (amiRNA)-based HCC gene therapy studies have demonstrated significant inhibition of invasion and induction of apoptosis of HCC cancer cells, indicating that this type of therapy may be a promising alternative to current therapeutics. Since the structure of the amiRNA precursor in the specific intracellular environment is critical for the processing to mature amiRNA, a precursor structure that may be efficiently processed is desired. In this study, we constructed amiRNAs targeting firefly luciferase with the precursor structures of six HCC-abundant microRNAs: miR-18a, miR-21, miR-192, miR-221, miR-222 and miR-224, and evaluated the processing efficiency of these amiRNAs in the HCC cell lines Hep3B and HepG2 using a luciferase reporter system. The results demonstrated that these amiRNA precursors are capable of being expressed in HCC cells, with the miR-221 precursor-based amiRNA exhibiting the most efficient inhibition on firefly luciferase at the levels of mRNA and protein activity. This finding provides a basis for constructing HCC-targeting amiRNAs with potent processing efficiency using the precursor structure of miR-221.

摘要

肝细胞癌(HCC)是全球最常见的恶性肿瘤之一,在发展中国家尤为如此。尽管临床治疗取得了进展,但HCC的死亡率仍然很高。一些基于人工微小RNA(amiRNA)的HCC基因治疗研究已证明对HCC癌细胞的侵袭有显著抑制作用,并能诱导其凋亡,这表明这种治疗方式可能是当前治疗方法的一种有前景的替代方案。由于特定细胞内环境中amiRNA前体的结构对于加工成成熟amiRNA至关重要,因此需要一种可能被有效加工的前体结构。在本研究中,我们构建了靶向萤火虫荧光素酶的amiRNA,其具有六种HCC高表达微小RNA(miR-18a、miR-21、miR-192、miR-221、miR-222和miR-224)的前体结构,并使用荧光素酶报告系统评估了这些amiRNA在HCC细胞系Hep3B和HepG2中的加工效率。结果表明,这些amiRNA前体能够在HCC细胞中表达,基于miR-221前体的amiRNA在mRNA和蛋白质活性水平上对萤火虫荧光素酶表现出最有效的抑制作用。这一发现为利用miR-221的前体结构构建具有高效加工效率的靶向HCC的amiRNA提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/db19a6a27760/ETM-06-01-0209-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/dbe18e6fe729/ETM-06-01-0209-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/9687beab8e2a/ETM-06-01-0209-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/f05ad620a932/ETM-06-01-0209-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/db19a6a27760/ETM-06-01-0209-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/dbe18e6fe729/ETM-06-01-0209-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/9687beab8e2a/ETM-06-01-0209-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/f05ad620a932/ETM-06-01-0209-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e12/3735510/db19a6a27760/ETM-06-01-0209-g03.jpg

相似文献

1
Construction of HCC-targeting artificial miRNAs using natural miRNA precursors.利用天然微小RNA前体构建靶向肝癌的人工微小RNA
Exp Ther Med. 2013 Jul;6(1):209-215. doi: 10.3892/etm.2013.1111. Epub 2013 May 14.
2
Inhibition of porcine reproductive and respiratory syndrome virus infection by recombinant adenovirus- and/or exosome-delivered the artificial microRNAs targeting sialoadhesin and CD163 receptors.重组腺病毒和/或外泌体递送靶向唾液酸粘附素和CD163受体的人工微小RNA对猪繁殖与呼吸综合征病毒感染的抑制作用
Virol J. 2014 Dec 19;11:225. doi: 10.1186/s12985-014-0225-9.
3
Enzymatic preparation of an artificial microRNA library.人工微小RNA文库的酶促制备。
Biochem Biophys Res Commun. 2009 Dec 18;390(3):791-6. doi: 10.1016/j.bbrc.2009.10.051. Epub 2009 Oct 15.
4
Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.微小RNA-30a-5p的过表达通过靶向MTDH/PTEN/AKT通路抑制肝癌细胞增殖并诱导其凋亡。
Tumour Biol. 2016 May;37(5):5885-95. doi: 10.1007/s13277-015-4456-1. Epub 2015 Nov 21.
5
Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.对微小RNA调控的蛋白质相互作用网络的综合分析揭示了微小RNA - 149通过靶向AKT - mTOR途径在人类肝细胞癌中的肿瘤抑制作用。
Mol Cancer. 2014 Nov 26;13:253. doi: 10.1186/1476-4598-13-253.
6
MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.微小 RNA-101 通过下调 EZH2 并增加细胞抑制性药物敏感性抑制人肝癌进展。
J Hepatol. 2014 Mar;60(3):590-8. doi: 10.1016/j.jhep.2013.10.028. Epub 2013 Nov 6.
7
MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.微小RNA-18a可抑制雌激素受体α的表达,从而促进肝癌细胞的增殖。
Gastroenterology. 2009 Feb;136(2):683-93. doi: 10.1053/j.gastro.2008.10.029. Epub 2008 Nov 1.
8
Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定肝癌中与侵袭转移相关的 microRNAs。
J Transl Med. 2018 Sep 29;16(1):266. doi: 10.1186/s12967-018-1639-8.
9
miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3.微小RNA-708通过靶向SMAD3在肝细胞癌中发挥肿瘤抑制作用。
Oncol Lett. 2017 Aug;14(2):2552-2558. doi: 10.3892/ol.2017.6429. Epub 2017 Jun 20.
10
MicroRNA-627-5p inhibits the proliferation of hepatocellular carcinoma cells by targeting BCL3 transcription coactivator.microRNA-627-5p 通过靶向 BCL3 转录共激活子抑制肝癌细胞的增殖。
Clin Exp Pharmacol Physiol. 2020 Mar;47(3):485-494. doi: 10.1111/1440-1681.13218. Epub 2019 Dec 21.

引用本文的文献

1
MicroRNA-574-3p inhibits the malignant behavior of liver cancer cells by targeting ADAM28.微小RNA-574-3p通过靶向ADAM28抑制肝癌细胞的恶性行为。
Oncol Lett. 2020 Sep;20(3):3015-3023. doi: 10.3892/ol.2020.11852. Epub 2020 Jul 10.
2
The microRNA and the perspectives of miR-302.微小RNA与miR-302的研究前景
Heliyon. 2019 Jan 25;5(1):e01167. doi: 10.1016/j.heliyon.2019.e01167. eCollection 2019 Jan.
3
Candidate miRNAs and pathogenesis investigation for hepatocellular carcinoma based on bioinformatics analysis.基于生物信息学分析的肝细胞癌候选微小RNA及发病机制研究

本文引用的文献

1
Effects of siRNA‑mediated Cdc2 silencing on MG63 cell proliferation and apoptosis.siRNA 介导的 Cdc2 沉默对 MG63 细胞增殖和凋亡的影响。
Mol Med Rep. 2013 Feb;7(2):466-70. doi: 10.3892/mmr.2012.1209. Epub 2012 Nov 28.
2
Asymmetric siRNA targeting the bcl‑2 gene inhibits the proliferation of cancer cells in vitro and in vivo.靶向 bcl-2 基因的不对称 siRNA 抑制体外和体内癌细胞的增殖。
Int J Oncol. 2013 Jan;42(1):253-60. doi: 10.3892/ijo.2012.1691. Epub 2012 Nov 7.
3
Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression.
Oncol Lett. 2017 May;13(5):3409-3414. doi: 10.3892/ol.2017.5913. Epub 2017 Mar 27.
4
Targeting MicroRNAs in Cancer Gene Therapy.癌症基因治疗中的微小RNA靶向作用
Genes (Basel). 2017 Jan 9;8(1):21. doi: 10.3390/genes8010021.
5
Identification a novel tumor-suppressive hsa-miR-599 regulates cells proliferation, migration and invasion by targeting oncogenic MYC in hepatocellular carcinoma.鉴定一种新型肿瘤抑制性人源 microRNA-599 通过靶向致癌基因 MYC 调控肝癌细胞的增殖、迁移和侵袭。
Am J Transl Res. 2016 Jun 15;8(6):2575-84. eCollection 2016.
6
Design of Effective Primary MicroRNA Mimics With Different Basal Stem Conformations.具有不同基础茎构象的有效初级微小RNA模拟物的设计
Mol Ther Nucleic Acids. 2016 Jan 12;5(1):e278. doi: 10.1038/mtna.2015.53.
7
Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma.基于生物标志物的微小 RNA 治疗策略治疗肝细胞癌。
J Clin Transl Hepatol. 2014 Dec;2(4):253-8. doi: 10.14218/JCTH.2014.00020. Epub 2014 Dec 15.
8
Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).人肝细胞癌中miR-28-5p表达下调通过靶向胰岛素样生长因子-1(IGF-1)与肿瘤增殖和迁移相关。
Mol Cell Biochem. 2015 Oct;408(1-2):283-93. doi: 10.1007/s11010-015-2506-z. Epub 2015 Jul 10.
9
DNA Polymerases as targets for gene therapy of hepatocellular carcinoma.DNA聚合酶作为肝细胞癌基因治疗的靶点。
BMC Cancer. 2015 Apr 29;15:325. doi: 10.1186/s12885-015-1339-1.
10
Optimization of Critical Hairpin Features Allows miRNA-based Gene Knockdown Upon Single-copy Transduction.关键发夹结构特征的优化可实现单拷贝转导后基于miRNA的基因敲低。
Mol Ther Nucleic Acids. 2014 Oct 28;3(10):e207. doi: 10.1038/mtna.2014.58.
利用携带 AFP 启动子控制 E1A 和 E1B 缺失以驱动 IL-24 表达的溶瘤腺病毒彻底清除肝癌。
Cancer Gene Ther. 2012 Sep;19(9):619-29. doi: 10.1038/cgt.2012.40. Epub 2012 Jul 13.
4
An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation.针对 HPSE 的人工 miRNA 抑制黑色素瘤侵袭特性,与下调趋化因子和 MAPK 磷酸化相关。
PLoS One. 2012;7(6):e38659. doi: 10.1371/journal.pone.0038659. Epub 2012 Jun 15.
5
Oncolytic viruses in the treatment of cancer: a review of current strategies.溶瘤病毒在癌症治疗中的应用:当前策略综述。
Pathol Oncol Res. 2012 Oct;18(4):771-81. doi: 10.1007/s12253-012-9548-2. Epub 2012 Jun 20.
6
Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression.自分泌胰岛素样生长因子-II对人肝癌HepG2细胞增殖及血管生成因子表达影响的抑制作用
Tumour Biol. 2012 Oct;33(5):1767-76. doi: 10.1007/s13277-012-0436-x. Epub 2012 Jun 10.
7
Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol.采用新的良好生产规范级方案生成的细胞因子诱导的杀伤细胞过继免疫疗法。
Cytotherapy. 2012 Aug;14(7):841-50. doi: 10.3109/14653249.2012.681038. Epub 2012 May 7.
8
MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.miR-128 通过靶向 p70S6K1 抑制肿瘤生长和血管生成。
PLoS One. 2012;7(3):e32709. doi: 10.1371/journal.pone.0032709. Epub 2012 Mar 19.
9
MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma.微小 RNA 谱分析肝癌发生,发现 C19MC 簇是肝癌的一种新的预后生物标志物。
Liver Int. 2012 May;32(5):772-82. doi: 10.1111/j.1478-3231.2012.02795.x. Epub 2012 Mar 19.
10
Anti-angiogenesis therapy in cancer: current challenges and future perspectives.癌症的抗血管生成治疗:当前的挑战与未来展望。
Cancer Lett. 2012 Jul 28;320(2):130-7. doi: 10.1016/j.canlet.2012.03.008. Epub 2012 Mar 13.